LIFECORE BIOMEDICAL, INC. Property, Plant and Equipment, Gross
LIFECORE BIOMEDICAL, INC. (LFCR) had Property, Plant and Equipment, Gross of $186.85 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-05
- 2026-06-30: Property, Plant and Equipment, Gross $186.85M.
- 2026-03-31: Property, Plant and Equipment, Gross $186.13M.
- 2025-12-31: Property, Plant and Equipment, Gross $186.46M.
- 2025-09-30: Property, Plant and Equipment, Gross $188.20M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $186.85M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $186.13M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $186.46M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $188.20M 10-Q · filed 2025-11-06 | |
| 2025-05-25 | $186.42M 10-KT · filed 2026-03-16 | |
| 2025-02-23 | $183.72M 10-Q · filed 2025-04-03 | |
| 2024-11-24 | $204.95M 10-Q · filed 2025-01-02 | |
| 2024-08-25 | $201.08M 10-Q · filed 2024-10-04 | |
| 2024-05-26 | $199.50M 10-KT · filed 2026-03-16 | $198.93M 10-K · filed 2024-08-26 |
| 2023-05-28 | $191.40M 10-K · filed 2024-08-26 | |
| 2022-05-29 | $165.53M 10-K · filed 2024-03-20 | $184.94M 10-K · filed 2022-09-14 |
| 2021-05-30 | $144.90M 10-K · filed 2024-03-20 | $282.16M 10-K · filed 2021-07-29 |
| 2020-05-31 | $287.25M 10-K · filed 2021-07-29 | |
| 2019-05-26 | $279.81M 10-K · filed 2020-08-14 | |
| 2018-05-27 | $228.51M 10-K · filed 2019-08-01 | |
| 2017-05-28 | $193.63M 10-K · filed 2018-08-09 | |
| 2016-05-29 | $174.85M 10-K/A · filed 2018-03-15 | |
| 2015-05-31 | $134.69M 10-K · filed 2016-08-01 | |
| 2014-05-25 | $118.97M 10-K · filed 2015-07-31 | |
| 2013-05-26 | $104.74M 10-K · filed 2014-08-01 | |
| 2012-05-27 | $97.47M 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |